Screening And Future Enhanced MRI
SAFE-MRI seeks to enhance breast cancer detection and MRI performance by implementing abbreviated screening for younger women and reducing contrast use through advanced imaging techniques.
Projectdetails
Introduction
SAFE-MRI aims to prevent needless mortality from breast cancer by optimizing the use and performance of dedicated breast MRI.
Objectives
First, SAFE-MRI aims at detecting breast cancer early in women that are currently deemed too young for population screening (age 45-50). Early diagnosis of breast cancer in these women will lead to a large gain in DALYs averted.
Screening Study
I will initiate a prospective screening study inviting women to a one-time only abbreviated breast MRI at the age of 45. The primary outcome will be the cancer detection rate per 1000 women actually screened. This will validate abbreviated breast MRI as a standalone screening technique.
Data Collection
Psycho-social and risk information will be collected from all participants. Cost-effectiveness modeling will be included. A 5-year follow-up will be performed in all women up to, and including, the first screening round at the age of 50.
Improvement of Breast MRI
Second, SAFE-MRI aims at improving breast MRI by reducing the need for contrast administration. This is a major downside of breast MRI for women (IV-cannulation and a small risk of allergic reactions) and the environment (pollution of surface water).
Enhanced Signal Changes
First, I aim to enhance signal changes using a strongly reduced dose of contrast with advanced deep learning (DL).
Unenhanced MRI Studies
Further studies are tailored at the assessment of unenhanced MRI. Particularly, I will validate novel diffusion weighted imaging (DWI) sequences capable of generating high-resolution diagnostic images within short scan times using DL-based reconstruction.
ASL Imaging Strategies
Furthermore, I will investigate arterial spin labeling (ASL) based breast imaging strategies that show perfusion without the need for contrast administration.
Synthetic Breast MRI Images
Finally, we will combine unenhanced MRI techniques in a generative adversarial network to construct synthetic breast MRI images. Repeated reader studies will be conducted to assess image quality and diagnostic value.
Conclusion
SAFE-MRI will thus consolidate my leading role in breast imaging and enable me to design the breast screening of the future.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.984.796 |
Totale projectbegroting | € 2.984.796 |
Tijdlijn
Startdatum | 1-6-2023 |
Einddatum | 31-5-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUMpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Revealing liver micrometastases in vivo using ultra-high definition MRIMicroMetSCAN aims to revolutionize MRI techniques for early detection of liver micrometastases, enhancing cancer diagnosis and treatment through improved imaging sensitivity and biological insights. | ERC Starting... | € 1.998.456 | 2025 | Details |
Transformative Pediatric Brain Cancer Imaging using Integrated Biophysics-AI Molecular MRIDevelop a novel AI-driven molecular MRI technology for rapid, noninvasive monitoring of pediatric brain cancer treatment response, enhancing precision medicine and understanding of tumor dynamics. | ERC Starting... | € 1.497.669 | 2024 | Details |
Low-dose breast CT with monochromatic x-ray sourcesMONOBREAST aims to enhance breast cancer imaging by integrating new monochromatic x-ray sources with advanced reconstruction methods to reduce radiation dose and improve diagnostic accuracy. | ERC Proof of... | € 150.000 | 2023 | Details |
Deuterium labeling of GLUCOse improves magnetic resonance imaging Sensitivity to CANcer metabolismGLUCO-SCAN aims to develop and clinically evaluate a novel whole-body deuterium metabolic imaging (DMI) method for cancer assessment, overcoming PET's limitations and enabling widespread screening. | ERC Consolid... | € 2.495.924 | 2023 | Details |
MAGNIFICO-Pre-commercialization of multifunctional targeted MRI-contrast enhancing agents for brain researchThis project aims to enhance MRI's capabilities for brain disease research by developing targeted fluorescent contrast agents and engineering cells for improved in vivo imaging. | ERC Proof of... | € 150.000 | 2022 | Details |
Revealing liver micrometastases in vivo using ultra-high definition MRI
MicroMetSCAN aims to revolutionize MRI techniques for early detection of liver micrometastases, enhancing cancer diagnosis and treatment through improved imaging sensitivity and biological insights.
Transformative Pediatric Brain Cancer Imaging using Integrated Biophysics-AI Molecular MRI
Develop a novel AI-driven molecular MRI technology for rapid, noninvasive monitoring of pediatric brain cancer treatment response, enhancing precision medicine and understanding of tumor dynamics.
Low-dose breast CT with monochromatic x-ray sources
MONOBREAST aims to enhance breast cancer imaging by integrating new monochromatic x-ray sources with advanced reconstruction methods to reduce radiation dose and improve diagnostic accuracy.
Deuterium labeling of GLUCOse improves magnetic resonance imaging Sensitivity to CANcer metabolism
GLUCO-SCAN aims to develop and clinically evaluate a novel whole-body deuterium metabolic imaging (DMI) method for cancer assessment, overcoming PET's limitations and enabling widespread screening.
MAGNIFICO-Pre-commercialization of multifunctional targeted MRI-contrast enhancing agents for brain research
This project aims to enhance MRI's capabilities for brain disease research by developing targeted fluorescent contrast agents and engineering cells for improved in vivo imaging.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Early detection of treatment response in breast cancerThe project aims to enhance breast cancer treatment through Hyperpolarized Magnetic Resonance imaging for early detection of non-responders, improving outcomes and reducing side effects. | EIC Transition | € 2.499.229 | 2024 | Details |
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic careMIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally. | EIC Transition | € 2.495.127 | 2022 | Details |
DDG-MRI for cancer detection - A novel medical imaging approach that correlates to FDG-PET without ionising radiationThe DDG-MRI project aims to develop a non-ionizing MRI technique using a novel deuterated glucose analogue to provide PET-like imaging for cancer detection and treatment monitoring. | EIC Pathfinder | € 2.991.061 | 2024 | Details |
BORSTKANKERDETECTIE D.M.V. CAMERATECHNOLOGIEËN/ ARTIFICIËLE INTELLIGENTIESigmascreening onderzoekt de haalbaarheid van een innovatief product voor borstkankerdetectie met 3D-camera's en AI, gericht op toegankelijkheid en marktbehoefte. | Mkb-innovati... | € 20.000 | 2020 | Details |
Haalbaarheidsproject Beter beeld voor een betere diagnoseHet project onderzoekt de toepassing van geavanceerde beeldverwerking in medische technieken om diagnoses te verbeteren en stralingsblootstelling voor patiënten te verminderen. | Mkb-innovati... | € 14.400 | 2021 | Details |
Early detection of treatment response in breast cancer
The project aims to enhance breast cancer treatment through Hyperpolarized Magnetic Resonance imaging for early detection of non-responders, improving outcomes and reducing side effects.
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care
MIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally.
DDG-MRI for cancer detection - A novel medical imaging approach that correlates to FDG-PET without ionising radiation
The DDG-MRI project aims to develop a non-ionizing MRI technique using a novel deuterated glucose analogue to provide PET-like imaging for cancer detection and treatment monitoring.
BORSTKANKERDETECTIE D.M.V. CAMERATECHNOLOGIEËN/ ARTIFICIËLE INTELLIGENTIE
Sigmascreening onderzoekt de haalbaarheid van een innovatief product voor borstkankerdetectie met 3D-camera's en AI, gericht op toegankelijkheid en marktbehoefte.
Haalbaarheidsproject Beter beeld voor een betere diagnose
Het project onderzoekt de toepassing van geavanceerde beeldverwerking in medische technieken om diagnoses te verbeteren en stralingsblootstelling voor patiënten te verminderen.